TELLGEN CORPORATION |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.26 CNY | +2.95% |
|
+3.27% | -24.87% |
| Sales 2022 | 716M 98.8M | Sales 2023 | 543M 74.91M | Capitalization | 2.88B 397M |
|---|---|---|---|---|---|
| Net income 2022 | 125M 17.25M | Net income 2023 | 89M 12.28M | EV / Sales 2022 | 3.98 x |
| Net cash position 2022 | 538M 74.19M | Net cash position 2023 | 483M 66.71M | EV / Sales 2023 | 4.41 x |
| P/E ratio 2022 |
27.1
x | P/E ratio 2023 |
32.2
x | Employees | 710 |
| Yield 2022 |
0.96% | Yield 2023 |
-
| Free-Float | 64.74% |
More Fundamentals
* Assessed data
More news
| 1 day | +2.95% | ||
| 1 week | +3.27% | ||
| Current month | -5.42% | ||
| 1 month | -6.42% | ||
| 3 months | -9.67% | ||
| 6 months | -26.46% | ||
| Current year | -24.87% |
1 week
12.23
13.27
1 month
11.8615.60
Current year
9.9418.02
1 year
9.9422.10
3 years
9.9450.25
5 years
9.9450.25
10 years
9.9450.25
| Managers | Title | Age | Since |
|---|---|---|---|
Jian Er Yao
CEO | Chief Executive Officer | 54 | 03-11-05 |
Xiao Qing Wang
BRD | Director/Board Member | 45 | 09-07-31 |
En Huan Yang
BRD | Director/Board Member | 42 | 09-03-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Jian Er Yao
CEO | Chief Executive Officer | 54 | 03-11-05 |
Zhang Fu Yu
BRD | Director/Board Member | 61 | 19-08-13 |
En Huan Yang
BRD | Director/Board Member | 42 | 09-03-31 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-24 | 13.26 | +2.95% | 1,362,410 |
| 24-04-23 | 12.88 | -0.62% | 2,119,620 |
| 24-04-22 | 12.96 | +3.27% | 1,624,820 |
| 24-04-19 | 12.55 | -1.41% | 973,610 |
| 24-04-18 | 12.73 | -0.86% | 1,645,700 |
End-of-day quote Shenzhen S.E., April 23, 2024
More quotes
Tellgen Corp is a company engaged in research, development, production and sales of in vitro diagnostic reagents and instruments. The Company's products are comprised of immunodiagnostic products, molecular diagnostic products and biochemical diagnostic products, including tumor marker detection products, human papillomavirus (HPV) nucleic acid testing products, autoimmune disease detection products and lung cancer methylation mutation detection products.
Calendar
2024-05-14
- Annual General Meeting
| 1st Jan change | Capi. | |
|---|---|---|
| -24.87% | 298M | |
| -0.40% | 12.72B | |
| -11.57% | 7.5B | |
| +1.54% | 5.48B | |
| +0.98% | 4.61B | |
| +5.18% | 4.47B | |
| -50.82% | 3.28B | |
| +11.23% | 2.71B | |
| -15.97% | 2.02B | |
| -10.84% | 1.74B |
- Stock Market
- Equities
- 300642 Stock
